SEARCH

SEARCH BY CITATION

REFERENCES

  • 1)
    Pettit , G. R. , Singh , S. B. , Hamel , E. , Lin , C. M. , Alberts , D. S. and Garcia-Kendall , D. Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4 . Experientia , 45 , 209211 ( 1989 ).
  • 2)
    El-Zayat , A. A. E. , Degen , D. , Drabek , S. , Clark , G. M. , Pettit , G. R. and von Hoff , D. D. In vitro evaluation of the antineoplastic activity of combretastatin A-4, a natural product from Combretum caffrum (arid shrub) . Anti-Cancer Drugs , 4 , 1925 ( 1993 ).
  • 3)
    Woods , J. A. , Hadfield , J. A. , Pettit , G. R. , Fox , B. W. and McGown , A. T. The interaction with tubulin of a series of stilbenes based on combretastatin A-4 . Br. J. Cancer , 71 , 705711 ( 1995 ).
  • 4)
    Pettit , G. R. and Rhodes , M. R. Antineoplastic agents 389. New syntheses of the combretastatin A-4 prodrug . Anti-Cancer Drug Design , 13 , 183191 ( 1998 ).
  • 5)
    Ohsumi , K. , Nakagawa , R. , Fukuda , Y. , Hatanaka , T. , Morinaga , Y. , Nihei , Y. , Ohishi , K. , Suga , Y. , Akiyama , Y. and Tsuji , T. Novel combretastatin analogues effective against murine solid tumors: design and structure-activity relationships . J. Med. Chem. , 41 , 30223032 ( 1998 ).
  • 6)
    Dark , G. G. , Hill , S. A. , Prise , V. E. , Tozer , G. M. , Pettit , G. R. and Chaplin , D. J. Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature . Cancer Res. , 57 , 18291834 ( 1997 ).
  • 7)
    Nihei , Y. , Suga , Y. , Morinaga , Y. , Ohishi , K. , Suzuki , M. , Okano , A. , Ohsumi , K. , Nakagawa , R. , Tsuji , T. , Akiyama , Y. and Tsuruo , T. A novel combretastatin A-4 derivative AC7700 shows marked antitumor activity against advanced solid tumors . 89th Annu. Meet. Am. Assoc. Cancer Res. , 77 ( 1998 ).
  • 8)
    Hori , K. , Suzuki , M. , Tanda , S. and Saito , S. In vivo analysis of tumor vascularization in the rat . Jpn. J. Cancer Res. , 81 , 279288 ( 1990 ).
  • 9)
    Hori , K. , Suzuki , M. , Tanda , S. , Saito , S. , Shinozaki , M. and Zhang , Q.-H. Circadian variation of tumor blood flow in rat subcutaneous tumors and its alteration by angiotensin II-induced hypertension . Cancer Res. , 52 , 912916 ( 1992 ).
  • 10)
    Shimosato , Y. and Watanabe , K. Enzymorphological observation on irradiated tumor, with a particular reference to acid hydrolase activity. I. Light microscopic study . Gann , 58 , 541550 ( 1967 ).
  • 11)
    Hori , K. , Li , H.-C. , Saito , S. and Sato , Y. Increased growth and incidence of lymph node metastases due to the angio-genesis inhibitor AGM-1470 . Br. J. Cancer , 75 , 17301734 ( 1997 ).
  • 12)
    Hori , K. , Suzuki , M. , Tanda , S. , Saito , S. , Shinozaki , M. and Zhang , Q.-H. Fluctuations in tumor blood flow under normotension and the effect of angiotensin II-induced hypertension . Jpn. J. Cancer Res. , 82 , 13091316 ( 1991 ).
  • 13)
    Suzuki , M. , Hori , K. , Saito , S. , Tanda , S. , Abe , I. , Sato , H. and Sato , H. Functional characteristics of tumor vessels: selective increase in tumor blood flow . Sci. Rep. Res. Inst. Tohoku Univ. Ser-C , 36 , 3745 ( 1989 ).
  • 14)
    Hori , K. , Zhang , Q.-H. , Li , H.-C. , Saito , S. and Sato , Y. Timing of cancer chemotherapy based on circadian variations in tumor tissue blood flow . Int. J. Cancer , 65 , 360364 ( 1996 ).
  • 15)
    Hori , K. , Saito , S. and Sato , Y. Daily changes in tumor blood flow after cancer chemotherapy . Microcirc. Annu. 1996 , 215216 ( 1996 ).
  • 16)
    Algire , G. H. , Legallais , F. Y. and Anderson , B. F. Vascular reaction of normal and malignant tissues in vivo. VI. The role of hypotension in the action of components of podophyllin on transplantable sarcomas . J. Natl. Cancer Inst. , 14 , 879893 ( 1954 ).
  • 17)
    Chaplin , D. J. and Acker , B. The effect of hydralazine on the tumor cytotoxicity of the hypoxic cell cytotoxin RSU-1069: evidence for therapeutic gain . Int. J. Radiat. Oncol. Biol. Phys. , 13 , 579585 ( 1987 ).
  • 18)
    Hill , S. , Williams , K. B. and Denekamp , J. Vascular collapse after flavone acetic acid: a possible mechanism of its anti-tumour action . Eur. J. Cancer Clin. Oncol. , 25 , 14191424 ( 1989 ).
  • 19)
    Hill , S. A. , Lonergan , S. J. , Denekamp , J. and Chaplin , D. J. Vinca alkaloids: anti-vascular effects in a murine tumour . Eur. J. Cancer , 29A , 13201324 ( 1993 ).
  • 20)
    Bibby , M. C. , Double , J. A. , Loadman , P. M. and Duke , C. V. Reduction of tumor blood flow by flavone acetic acid: a possible component of therapy . J. Natl. Cancer Inst. , 81 , 216220 ( 1989 ).
  • 21)
    Zwi , L. J. , Baguley , B. C. , Gavin , J. B. and Wilson , W. R. Blood flow failure as a major determinant in the antitumor action of flavone acetic acid . J. Natl. Cancer Inst. , 81 , 100501013 ( 1989 ).
  • 22)
    Baguley , B. C. , Holdaway , K. M. , Thomsen , L. L. , Zhuang , L. and Zwi , L. J. Inhibition of growth of colon 38 adeno-carcinoma by vinblastine and colchicine: evidence for a vascular mechanism . Eur. J. Cancer , 27 , 482487 ( 1991 ).
  • 23)
    Horsman , M. R. , Christensen , K. L. and Overgaard , J. Relationship between the hydralazine-induced changes in murine tumor blood flow supply and mouse blood pressure . Int. J. Radiat. Oncol. Biol. Phys. , 22 , 455458 ( 1992 ).
  • 24)
    Cater , D. B. , Grigson , C. M. B. and Watkinson , D. A. Changes of oxygen tension in tumours induced by vasoconstrictor and vasodilator drugs . Acta Radiol. , 58 , 401434 ( 1962 ).
  • 25)
    Suzuki , M. Selective increase in intratumoral concentration of anticancer drugs and extension of retention time based on two functional characteristics of tumor vessels . Adv. Cancer Treat. , 7 , 7781 ( 1988 ) ( in Japanese ).
  • 26)
    Krossnes , B. K. , Mella , O. and Tyssebotn , I. Effect of sodium nitroprusside-induced hypotension on the blood flow in subcutaneous and intramuscular BT4AN tumors and normal tissues in rats . Int. J. Radiat. Oncol. Biol. Phys. , 36 , 393401 ( 1996 ).
  • 27)
    Kallinowski , F. , Shaefer , C. , Tyler , G. and Vaupel , P. In vivo targets of recombinant human tumour necrosis factor—blood flow, oxygen consumption and growth of isotrans-planted rat tumours . Br. J. Cancer , 60 , 555560 ( 1989 ).
  • 28)
    Tozer , G. M. , Prise , V. E. and Chaplin , D. J. Inhibition of nitric oxide synthase induces a selective reduction in tumor blood flow that is reversible with L-arginine . Cancer Res. , 57 , 948955 ( 1997 ).
  • 29)
    Iyer , S. , Chaplin , D. J. , Rosenthal , D. S. , Boulares , H. , Li , L.-Y. and Smulson , M. E. Induction of apoptosis in proliferating human endothelial cells by the tumor-specific anti-angiogenesis agent combretastatin A-4 . Cancer Res. , 58 , 45104514 ( 1998 ).
  • 30)
    Hori , K. , Zhang , Q.-H. , Saito , S. , Tanda , S. , Li , H.-C. and Suzuki , M. Microvascular mechanisms of change in tumor blood flow due to angiotensin II, epinephrine, and methoxamine: a functional morphometric study . Cancer Res. , 53 , 55285534 ( 1993 ).